SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020100
Filing Date
2023-05-10
Accepted
2023-05-10 08:02:40
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-20230331.htm   iXBRL 10-Q 1910042
2 EX-3.3 pmvp-ex3_3.htm EX-3 330332
3 EX-31.1 pmvp-ex31_1.htm EX-31 22499
4 EX-31.2 pmvp-ex31_2.htm EX-31 22468
5 EX-32.1 pmvp-ex32_1.htm EX-32 11796
6 EX-32.2 pmvp-ex32_2.htm EX-32 12390
  Complete submission text file 0000950170-23-020100.txt   7838162

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pmvp-20230331_def.xml EX-101.DEF 119120
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pmvp-20230331_cal.xml EX-101.CAL 40720
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pmvp-20230331.xsd EX-101.SCH 47124
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pmvp-20230331_lab.xml EX-101.LAB 390155
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pmvp-20230331_pre.xml EX-101.PRE 273044
58 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20230331_htm.xml XML 1546502
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 23904410
SIC: 2834 Pharmaceutical Preparations